The Effects of Neoadjuvant Chemoradiation on pTNM Staging and Its Prognostic Significance in Esophageal Cancer

Journal of Gastrointestinal Surgery

Volumn 10, Issue 9, 2006, Pages 1301-1311

  Law, Simon ^a   Kwong, Dora L W ^a   Wong, Kam Ho ^a   Kwok, Ka Fai ^a   Wong, John ^a  

^a Department of Clinical Oncology ^*  (Hong Kong)

Author keywords

chemoradiation; Esophageal neoplasm; multimodality treatment; prognosis; staging

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RADIATION DOSE FRACTIONATION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS;

EID: 33751233550     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2006.06.009     Document Type: Article

References (41)

1. Whooley B.P., Law S., Murthy S.C., Alexandrou A., and Wong J. Analysis of reduced death and complication rates after esophageal resection. Ann Surg 233 (2001) 338-344
2. Siewert J.R., Feith M., Werner M., and Stein H.J. Adenocarcinoma of the esophagogastric junction: Results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 232 (2000) 353-361
3. Swisher S.G., Deford L., Merriman K.W., et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg 119 (2000) 1126-1132
4. Law S., Wong K.H., Kwok K.F., Chu K.M., and Wong J. Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg 240 (2004) 791-800
5. Ando N., Ozawa S., Kitagawa Y., Shinozawa Y., and Kitajima M. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232 (2000) 225-232
6. Watanabe H., Kato H., and Tachimori Y. Significance of extended systemic lymph node dissection for thoracic esophageal carcinoma in Japan. Recent Results Cancer Res 155 (2000) 123-133
7. Hagen J.A., DeMeester S.R., Peters J.H., Chandrasoma P., and DeMeester T.R. Curative resection for esophageal adenocarcinoma: Analysis of 100 en bloc esophagectomies. Ann Surg 234 (2001) 520-530
8. Ellis-FH J., Heatley G.J., Krasna M.J., Williamson W.A., and Balogh K. Esophagogastrectomy for carcinoma of the esophagus and cardia: A comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J Thorac Cardiovasc Surg 113 (1997) 836-846
9. Hulscher J.B., Tijssen J.G., Obertop H., and van Lanschot J.J. Transthoracic versus transhiatal resection for carcinoma of the esophagus: A meta-analysis. Ann Thorac Surg 72 (2001) 306-313
10. Daly J.M., Fry W.A., Little A.G., et al. Esophageal cancer: Results of an American College of Surgeons Patient Care Evaluation Study. J Am Coll Surg 190 (2000) 562-572
11. Suntharalingam M., Moughan J., Coia L.R., et al. Outcome results of the 1996-1999 patterns of care survey of the national practice for patients receiving radiation therapy for carcinoma of the esophagus. J Clin Oncol 23 (2005) 2325-2331
12. Bosset J.F., Gignoux M., Triboulet J.P., et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337 (1997) 161-167
13. Walsh T.N., Noonan N., Hollywood D., Kelly A., Keeling N., and Hennessy T. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335 (1996) 462-467
14. Urba S.G., Orringer M.B., Turrisi A., Iannettoni M., Forastiere A., and Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19 (2001) 305-313
15. Le Prise E., Etienne P.L., Meunier B., et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73 (1994) 1779-1784
16. Burmeister B.H., Smithers B.M., Gebski V., et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: A randomised controlled phase III trial. Lancet Oncol 6 (2005) 659-668
17. Law S., Kwong D.L., Kwok K.F., et al. Improvement in treatment results and long-term survival of patients with esophageal cancer: Impact of chemoradiation and change in treatment strategy. Ann Surg 238 (2003) 339-348
18. Swisher S.G., Maish M., Erasmus J.J., et al. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78 (2004) 1152-1160
19. Law S., and Wong J. Current management of esophageal cancer. J Gastrointest Surg 9 (2005) 291-310
20. Law S., Fok M., Chu K.M., and Wong J. Thoracoscopic esophagectomy for esophageal cancer. Surgery 122 (1997) 8-14
21. Law S.Y., Fok M., and Wong J. Pattern of recurrence after oesophageal resection for cancer: Clinical implications. Br J Surg 83 (1996) 107-111
22. Law S., and Wong J. Two-field dissection is enough for esophageal cancer. Dis Esophagus 14 (2001) 98-103
23. Dresner S.M., Wayman J., Shenfine J., Harris A., Hayes N., and Griffin S.M. Pattern of recurrence following subtotal oesophagectomy with two field lymphadenectomy. Br J Surg 87 (2000) 362-373
24. Davis P.A., Law S., and Wong J. Colonic interposition after esophagectomy for cancer. Arch Surg 138 (2003) 303-308
25. Law S, Wong J. Esophagogastrectomy for carcinoma of the esophagus and cardia, and the esophageal anastomosis. In Baker RJ, Fischer JE, eds. Mastery of Surgery. Philadelphia, PA: Lippincott Williams & Wilkins, 2001, pp 813-827.
26. Law S, Wong J. Esophagectomy without thoracotomy. In Baker RJ, Fischer JE, eds. Mastery of Surgery. Philadelphia, PA: Lippincott Williams & Wilkins, 2001, pp 828-836.
27. American Joint Committee on Cancer. Esophagus. In: Greene F.L. (Ed). AJCC Cancer Staging Manual (2002), Springer Verlag, New York 91-95
28. Wittekind C., Compton C.C., Greene F.L., and Sobin L.H. TNM residual tumor classification revisited. Cancer 94 (2002) 2511-2516
29. Urschel J.D., and Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185 (2003) 538-543
30. Fiorica F., Di Bona D., Schepis F., et al. Preoperative chemoradiotherapy for oesophageal cancer: A systematic review and meta-analysis. Gut 53 (2004) 925-930
31. Chirieac L.R., Swisher S.G., Ajani J.A., et al. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer 103 (2005) 1347-1355
32. Swisher S.G., Hofstetter W., Wu T.T., et al. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg 241 (2005) 810-817
33. Akiyama H., Tsurumaru M., Udagawa H., and Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 220 (1994) 364-372
34. Gaca J.G., Petersen R.P., Peterson B.L., et al. Pathologic nodal status predicts disease-free survival after neoadjuvant chemoradiation for gastroesophageal junction carcinoma. Ann Surg Oncol 13 (2006) 340-346
35. Gu Y., Swisher S.G., Ajani J.A., et al. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer 106 (2006) 1017-1025
36. Rohatgi P., Swisher S.G., Correa A.M., et al. Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. Cancer 104 (2005) 2365-2372
37. Donington J.S., Miller D.L., Allen M.S., Deschamps C., Nichols III F.C., and Pairolero P.C. Tumor response to induction chemoradiation: Influence on survival after esophagectomy. Eur J Cardiothorac Surg 24 (2003) 631-636
38. Rusch V.W. Should the esophageal cancer staging system be revised?. J Thorac Cardiovasc Surg 125 (2003) 992-993
39. Korst R.J., Rusch V.W., Venkatraman E., et al. Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 115 (1998) 660-669
40. Rice T.W., Blackstone E.H., Rybicki L.A., et al. Refining esophageal cancer staging. J Thorac Cardiovasc Surg 125 (2003) 1103-1113
41. Japanese Society for Esophageal Diseases. Guidelines for Clinical and Pathologic Studies on Carcinoma of the Esophagus (2001), Kanehara & Co Ltd, Tokyo